Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Atellica® CH Diazo Total Bilirubin (D_TBil)

K-Number: K222104 · 2023-03-20

Decision Date2023-03-20
Product CodeCIG
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Atellica® CH Diazo Total Bilirubin (D_TBil) is a medical device manufactured by Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2023-03-20 under approval number K222104. The device is classified under product code CIG. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Atellica® CH Diazo Total Bilirubin (D_TBil)?

Atellica® CH Diazo Total Bilirubin (D_TBil) is a medical device that received FDA 510(k) clearance on 2023-03-20. It is manufactured by Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K222104.

When was Atellica® CH Diazo Total Bilirubin (D_TBil) approved by the FDA?

Atellica® CH Diazo Total Bilirubin (D_TBil) received FDA 510(k) clearance on 2023-03-20, under approval number K222104.

What company makes Atellica® CH Diazo Total Bilirubin (D_TBil)?

Atellica® CH Diazo Total Bilirubin (D_TBil) is manufactured by Siemens Healthcare Diagnostics, Inc..

What is the FDA product code for Atellica® CH Diazo Total Bilirubin (D_TBil)?

The FDA product code for Atellica® CH Diazo Total Bilirubin (D_TBil) is CIG.

Related Clinical Trials

Other Devices by Siemens Healthcare Diagnostics, Inc.

View all 71 devices →

Related Devices (Code: CIG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.